• BMS 493 br Materials and methods Patients charts were review

  2022-01-03

  

  Materials and methods Patients’ charts were reviewed retrospectively, and 165 consecutive patients (82 with cancer and 83 without cancer) who either started edoxaban (Lixiana®, Daiichi-Sankyo, Tokyo, Japan) therapy for the treatment of VTE or were switched from other oral anticoagulants to edoxab

• br Factor Xa an enzyme in the coagulation

  2022-01-03

  

  Factor Xa, an enzyme in the coagulation cascade, has recently been identified as having a role in inflammation, generating interest in factor Xa inhibitors as anti-inflammatory agents beyond their established use as anticoagulants [, , , ]. We report sustained clinical and electrophysiologic impro

• Whether histamine receptor distribution is altered

  2022-01-03

  

  Whether histamine receptor distribution is altered in canine GI diseases remains unknown, but human research has documented altered histamine receptor density in certain GI diseases (Sander et al., 2006, Deiteren et al., 2015, Von Rahden et al., 2011). Additionally, a novel H4 receptor antagonist, J

• Histamine H and H receptors are considered as

  2022-01-03

  

  Histamine H1 and H2 receptors are considered as low affinity receptors (pKi of 4.2 and 4.3 respectively), whereas histamine H3 and H4 receptors as a high affinity receptors (pKi of 8 and 8.2 respectively) (Schreeb et al., 2013). Therefore it might well be that other histamine receptors might be invo

• The overall characteristic of RNA profile of

  2022-01-03

  

  The overall characteristic of RNA profile of Leydig cell is still a mystery. Variation in total RNA will cause subsequent difference in protein expression and phenotypic modulation [16]. In this study, we used a murine nicotine exposure model coupled with next generation RNA sequencing (NGS) and fou

• SB 216763 Recent studies have indicated that HDAC and BRD

  2022-01-03

  

  Recent studies have indicated that HDAC and BRD4 are associated with similar biological phenotypes related to cancer and combination of the HDAC inhibitor LBH589 and BET inhibitor I-BET151 synergistically induces apoptosis of melanoma cells [20], [21]. Moreover, combination of Panobinostat and (+)-J

7866 records 525/525 page Previous First page 上5页 521522523524525